Table 2 Operative and pathological details and outcomes

Median operative time (IQR), mins

189 (170–200)

Median estimated blood loss (IQR), mL

150 (100–200)

Median prostate weight (IQR), gm

44.7 (38–57.1)

Blood transfusions

1 (1.8%)

Lymph node dissection

37 (69.8%)

Complete nerve sparing

37 (69.8%)

Median hospital stay (IQR), days

1 (1–1)

Median lymph nodes retrieved (IQR)

17 (12–21)

Positive LN

5 (9.4%)

Median tumor size (IQR), cc

6.9 (2.6–13.7)

Positive margins

20 (41.5%)

Seminal vesicle involvement

6 (11.3%)

Extra capsular extension

15 (28.3%)

Perineural invasion

44 (83.0%)

Extensive prostatic intraepithelial neoplasia

5 (9.4%)

Vascular/Lymphatic invasion

10 (18.8%)

Pathologic T stage

 T2a-c

29 (54.7%)

 T3a-b

21 (39.6%)

 T4

3 (5.7%)

Pathologic Gleason score

 ≤ 6

13 (24.5%)

 7

16 (30.2%)

 ≥ 8

24 (45.3%)